Literature DB >> 19329230

[Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].

Miguel Angel Díaz1, José Ramón Hernández, Luis Martínez-Martínez, Jesús Rodríguez-Baño, Alvaro Pascual.   

Abstract

INTRODUCTION: During the year 2000, the 1st nationwide project (GEIH-BLEE Project 2000) on Escherichia coli and Klebsiella pneumoniae producing extended-spectrum ss-lactamases (ESBL) was carried out in Spain. The 2nd nationwide study was developed in 2006 to investigate the evolution of this problem.
METHODS: A prospective multicenter study was designed, including all ESBL-producing E. coli and K. pneumoniae strains isolated at 44 Spanish hospitals between February and March 2006. Identification was verified at the coordinating centre and ESBL production was confirmed following CLSI guidelines.
RESULTS: A total of 1021 E. coli and 162 K. pneumoniae strains were collected. ESBL-producing E. coli strains were isolated in all the participating hospitals, whereas ESBL-producing K. pneumoniae were isolated in 34. The overall percentage (range) of ESBL production among E. coli and K. pneumoniae was 4.04% (0.4-20.3) and 5.04% (0-30), respectively. In ESBL E. coli (Ec) cases, acquisition was considered community-acquired in 32%, related to health care in 36%, and nosocomial in 30%; and in ESBL K. pneumoniae (Kp) cases, acquisition by these routes was 10%, 18%, and 68% respectively. The samples most commonly showing these microorganisms were urine (77% Ec and 48.2% Kp) and wound exudate (8.6% Ec and 14.8% Kp).
CONCLUSIONS: Since 2000, the percentage of ESBL-producing strains among E. coli and K. pneumoniae isolates in Spain has increased 8-fold and 2-fold, respectively. The increase in ESBL-producing E. coli mainly occurred in isolates from outpatients, and most commonly in urine samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329230     DOI: 10.1016/j.eimc.2008.09.006

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  15 in total

1.  Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features.

Authors:  C Ruiz de Alegría; J Rodríguez-Baño; M E Cano; J R Hernández-Bello; J Calvo; E Román; M A Díaz; A Pascual; L Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

2.  Fulminant mediastinitis due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: atypical presentation and spreading following cardiac surgery.

Authors:  Horacio Valenzuela; Yolanda Carrascal; Laura Maroto; Nuria Arce
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-14

3.  Cefotaxime resistance and outcome of Klebsiella spp bloodstream infection.

Authors:  M Ortega; F Marco; A Soriano; M Almela; J A Martínez; J López; C Pitart; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-21       Impact factor: 3.267

4.  Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.

Authors:  Miguel A Díaz; José R Hernández-Bello; Jesús Rodríguez-Baño; Luis Martínez-Martínez; Jorge Calvo; Jorge Blanco; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

5.  Prevalence of Aminoglycoside-Modifying Enzymes in Escherichia coli and Klebsiella pneumoniae Producing Extended Spectrum β-Lactamases Collected in Two Multicenter Studies in Spain.

Authors:  Marta Fernández-Martínez; Belén Ruiz Del Castillo; Maria Jesús Lecea-Cuello; Jesús Rodríguez-Baño; Álvaro Pascual; Luis Martínez-Martínez
Journal:  Microb Drug Resist       Date:  2017-10-03       Impact factor: 3.431

6.  MrkD1P from Klebsiella pneumoniae strain IA565 allows for coexistence with Pseudomonas aeruginosa and protection from protease-mediated biofilm detachment.

Authors:  Brandon M Childers; Tricia A Van Laar; Tao You; Steven Clegg; Kai P Leung
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

7.  Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.

Authors:  Jorge Blanco; Azucena Mora; Rosalia Mamani; Cecilia López; Miguel Blanco; Ghizlane Dahbi; Alexandra Herrera; Juan Marzoa; Val Fernández; Fernando de la Cruz; Luis Martínez-Martínez; María Pilar Alonso; Marie-Hélène Nicolas-Chanoine; James R Johnson; Brian Johnston; Lorena López-Cerero; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  J Clin Microbiol       Date:  2013-08-07       Impact factor: 5.948

8.  CTX-M Enzymes: Origin and Diffusion.

Authors:  Rafael Cantón; José María González-Alba; Juan Carlos Galán
Journal:  Front Microbiol       Date:  2012-04-02       Impact factor: 5.640

9.  WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain.

Authors:  Marta Hernández-García; Sergio García-Fernández; María García-Castillo; Germán Bou; Emilia Cercenado; Mercedes Delgado-Valverde; Xavier Mulet; Cristina Pitart; Jesús Rodríguez-Lozano; Nuria Tormo; Diego López-Mendoza; Jazmín Díaz-Regañón; Rafael Cantón
Journal:  JAC Antimicrob Resist       Date:  2020-10-22

10.  Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality.

Authors:  Ana Díaz-Martín; María Luisa Martínez-González; Ricard Ferrer; Carlos Ortiz-Leyba; Enrique Piacentini; Maria Jesus Lopez-Pueyo; Ignacio Martín-Loeches; Mitchell M Levy; Antoni Artigas; José Garnacho-Montero
Journal:  Crit Care       Date:  2012-11-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.